Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Tumour Diseases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT01259284
What this trial is testing

Fish Oil Versus Statins Versus Placebos in Reducing Atrial Fibrillation in Patients Undergoing Thoracic Surgery for Lung Cancer

Who this might be right for
Advanced Cancers
M.D. Anderson Cancer Center 2
Very early researchUnknownNCT06054984
What this trial is testing

TCR-T Cells in the Treatment of Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Ruijin Hospital 18
Large-scale testing (Phase 3)Ended earlyNCT00551733
What this trial is testing

Carboplatin With Either Paclitaxel Poliglumex or Paclitaxel in Treating Women With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
CTI BioPharma 450
Not applicableStudy completedNCT04186884
What this trial is testing

Caregiver Burden, Quality of Life, and Symptom Distress at Different Palliative Cancer Care Settings

Who this might be right for
Advanced Malignant NeoplasmLocally Advanced Malignant NeoplasmMetastatic Malignant Neoplasm+1 more
M.D. Anderson Cancer Center 351
Testing effectiveness (Phase 2)Study completedNCT01175733
What this trial is testing

Chemoradiation With Gemcitabine in Combination With Panitumumab for Patients With Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Amsterdam UMC, location VUmc 18
Testing effectiveness (Phase 2)UnknownNCT05420584
What this trial is testing

Neoadjuvant Arterial Embolization Chemotherapy Combined PD-1 Inhibitor for Locally Advanced Rectal Cancer

Who this might be right for
Rectal Neoplasms
The Fourth Affiliated Hospital of Zhejiang University School of Medicine 83
Testing effectiveness (Phase 2)WithdrawnNCT05045404
What this trial is testing

Poziotinib and Ramucirumab for the Treatment of EGFR Exon 20 Mutant Stage IV Non-small Cell Lung Cancer

Who this might be right for
Metastatic Lung Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8Stage IVA Lung Cancer AJCC v8+1 more
M.D. Anderson Cancer Center
Large-scale testing (Phase 3)Study completedNCT02399306
What this trial is testing

Chemoradiotherapy With or Without Enteral Nutrition for Locally Advanced Thoracic Esophageal Carcinoma

Who this might be right for
Esophageal Squamous Cell CarcinomaEnteral Nutrition TherapyChemoradiotherapy
Sichuan Cancer Hospital and Research Institute 222
Testing effectiveness (Phase 2)Looking for participantsNCT07162506
What this trial is testing

DCRT vs. Surgery in Resectable ESCC Patient Achiving cCR/PR After nCI

Who this might be right for
Esophageal Cancer
Tianjin Medical University Cancer Institute and Hospital 120
Large-scale testing (Phase 3)UnknownNCT00154752
What this trial is testing

Concurrent Chemoradiation Versus Wide Pelvic Lymphadenectomy for Advanced Rectal Cancer

Who this might be right for
Colorectal Cancer
National Taiwan University Hospital 200
Early research (Phase 1)Looking for participantsNCT07564232
What this trial is testing

Phase 1 Study Of LNK001 In Advanced Or Metastatic Clear Cell Renal Cell Carcinoma

Who this might be right for
Clear Cell Renal Cell Carcinoma
M.D. Anderson Cancer Center 40
Testing effectiveness (Phase 2)WithdrawnNCT03841747
What this trial is testing

Paclitaxel Plus Pembrolizumab vs. Paclitaxel Weekly in ER+ Luminal B Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Queen Mary University of London
Post-approval studies (Phase 4)UnknownNCT05897749
What this trial is testing

Clinical Study on the Effect of Brucea Javanica Oil Emulsion Injection on the Survival of Patients With Advanced Colorectal Cancer Who Failed to Receive Multi-line Treatment

Who this might be right for
Colorectal CancerChinese Herbal MedicineProgression-free Survival+1 more
Guang'anmen Hospital of China Academy of Chinese Medical Sciences 60
Testing effectiveness (Phase 2)Study completedNCT05898763
What this trial is testing

TEIPP Immunotherapy in Patients With NSCLC

Who this might be right for
Non Small Cell Lung Cancer
Erasmus Medical Center 26
Testing effectiveness (Phase 2)Ended earlyNCT05357898
What this trial is testing

Study of SQZ-eAPC-HPV in Patients With HPV16+ Recurrent, Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Adult Solid Tumor
SQZ Biotechnologies 20
Testing effectiveness (Phase 2)UnknownNCT06564298
What this trial is testing

A Study on the Combination of Sintilimab, Ramucirumab and Chemotherapy for First-line Treatment of Gastric Cancer With Liver Metastasis

Who this might be right for
Stomach Neoplasms
The First Affiliated Hospital with Nanjing Medical University 39
Testing effectiveness (Phase 2)Study completedNCT02106884
What this trial is testing

Quality of Life in Locally Advanced or Metastatic Pancreatic Cancer Treated With Gemcitabine and Nab-paclitaxel

Who this might be right for
Pancreatic Cancer
Universitaire Ziekenhuizen KU Leuven 146
Early research (Phase 1)WithdrawnNCT01490047
What this trial is testing

Single Dose of Intravenous rhTNF-α and Liposomal Doxorubicin in Patients With Advanced Solid Tumors or Lymphomas

Who this might be right for
Solid TumorsLymphomas
Ludwig Institute for Cancer Research
Testing effectiveness (Phase 2)Study completedNCT00411632
What this trial is testing

BATTLE Program: Tarceva and Targretin in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Lung Cancer
M.D. Anderson Cancer Center 37
Not applicableUnknownNCT05996263
What this trial is testing

Prognostic Value of Combined Approach Based on KEAP1/NFE2L2 Mutations and Pre-therapeutic FDG-PET/CT Radiomic Analysis in Advanced Non-small-cell Lung Cancer PDL1 ≥ 50% Treated With Pembrolizumab (PEMBROMIC)

Who this might be right for
Lung Cancer Stage IIILung Cancer Stage IV
University Hospital, Brest 75
Next Page